Glenmark Pharmaceuticals Limited — Others, 14-08-2025: Change in Auditors

Glenmark Pharmaceuticals' board approved the transfer of its Consumer Care business to a new wholly-owned subsidiary, Glenmark Consumer Care Limited. This strategic move aims to boost growth and operational focus in the consumer segment. Last fiscal, this business contributed ₹514.7 Cr in turnover and ₹249.2 Cr in net worth, with the transfer valued at approximately ₹240.40 Cr. Additionally, Ms. Patricia Andrews, an experienced biopharma executive, was appointed as an Independent Director. The company also appointed M/s. Walker Chandiok & Co., LLP as Statutory Auditors and M/s. Rauthan & Associates LLP as Secretarial Auditors for five-year terms. The 47th Annual General Meeting is set for September 26, 2025.